Cargando…

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Detalles Bibliográficos
Autor principal: Gersh, Felice L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241320/
https://www.ncbi.nlm.nih.gov/pubmed/32622456
http://dx.doi.org/10.1016/j.mayocp.2020.05.001
_version_ 1783537045344354304
author Gersh, Felice L.
author_facet Gersh, Felice L.
author_sort Gersh, Felice L.
collection PubMed
description
format Online
Article
Text
id pubmed-7241320
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mayo Foundation for Medical Education and Research
record_format MEDLINE/PubMed
spelling pubmed-72413202020-05-21 Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Gersh, Felice L. Mayo Clin Proc Article Mayo Foundation for Medical Education and Research 2020-07 2020-05-21 /pmc/articles/PMC7241320/ /pubmed/32622456 http://dx.doi.org/10.1016/j.mayocp.2020.05.001 Text en © 2020 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gersh, Felice L.
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_full Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_fullStr Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_full_unstemmed Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_short Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
title_sort angiotensin-converting enzyme 2 and the resolution of inflammation: in support of continuation of prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241320/
https://www.ncbi.nlm.nih.gov/pubmed/32622456
http://dx.doi.org/10.1016/j.mayocp.2020.05.001
work_keys_str_mv AT gershfelicel angiotensinconvertingenzyme2andtheresolutionofinflammationinsupportofcontinuationofprescribedangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockers